Lipton, Richard B. http://orcid.org/0000-0003-2652-2897
Buse, Dawn C.
Nahas, Stephanie J. http://orcid.org/0000-0001-8846-8393
Tietjen, Gretchen E. http://orcid.org/0000-0003-0524-5683
Martin, Vincent T.
Löf, Elin
Brevig, Thomas
Cady, Roger
Diener, Hans-Christoph http://orcid.org/0000-0002-6556-8612
Funding for this research was provided by:
H. Lundbeck A/S
Universitätsklinikum Essen
Article History
Received: 5 May 2023
Revised: 12 July 2023
Accepted: 13 July 2023
First Online: 24 August 2023
Declarations
:
: Dr. Lipton has been a consultant, advisory board member, and/or has received honoraria from Allergan/AbbVie, American Academy of Neurology, American Headache Society, Amgen, BioDelivery Sciences, Biohaven Pharmaceuticals, BioVision, electroCore, Eli Lilly, GlaxoSmithKline, Impel, Lundbeck Seattle BioPharmaceuticals, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, and Vedanta; has stock or stock options in Biohaven Pharmaceuticals and Manistee; and has received research support from Amgen, the FDA, the National Headache Foundation, and the NIH. Dr. Buse has received grant support from Amgen, the FDA, and the National Headache Foundation; has served as a consultant and received honoraria from Allergan/AbbVie, Amgen/Novartis, Biohaven, Collegium, Eli Lilly, Lundbeck, and Teva; and has served on the editorial board of <i>Current Pain and Headache Reports.</i> Dr. Nahas has received honoraria for consulting from Alder/Lundbeck, Allergan/AbbVie, Amgen/Novartis (inactive), Axsome (inactive), BioDelivery Sciences (inactive), Biohaven (inactive), Eli Lilly, Fenix Group International (inactive), Teva (inactive), and Theranica (inactive); has received honoraria for speaking from Allergan/AbbVie, Amgen/Novartis, Eli Lilly, and Teva (all inactive); has received honoraria for work in education or publishing from American Academy of Neurology, American Headache Society, Evolve Med Ed, Massachusetts Medical Society, MedLink Neurology, MJH Life Sciences, NACCME, Neurology Learning Network, Pennsylvania Neurologic Society, Pri-Med, Springer, WebMD/Medscape, and Wolters-Kluwer; and has received legal fees for serving as a medical expert to Jackson & Campbell. Dr. Tietjen has been a consultant for Lundbeck and Impel; has presented lectures for CME Outfitters and American Medical Women’s Association; has received an award from the American Headache Society; has received support for teaching or presenting in meetings at the Annual Scientific Meeting of the American Headache Society and Annual Meeting of the American Academy of Neurology; has been a committee chair member for the American Headache Society; and owns stock or an ownership interest in Johnson & Johnson. Dr. Martin has been a consultant for AbbVie, Biohaven, Theranica, Impel, Bioscience Delivery, and Lundbeck, and has been a speaker for AbbVie, Impel, Lundbeck, and Satsuma. Dr. Löf is an employee of Lundbeck or one of its subsidiary companies. Dr. Brevig and Dr. Cady were previously employees of Lundbeck. Prof. Diener has received honoraria for contribution to advisory boards or oral presentations from Eli Lilly, Lundbeck, Novartis, Pfizer, and Teva; has received research support from the German Research Council (DFG), and the German Ministry of Education and Research (BMBF); has served on the editorial boards of <i>Cephalalgia</i>, <i>Lancet Neurology</i>, and <i>Drugs</i>; and has served as a member of the Clinical Trials Committee of the IHS.
: As a review article, ethics approval is not applicable.
: As a review article, consent to participate/publish is not applicable.